Poststroke dendritic arbor regrowth requires the actin nucleator Cobl

PLoS Biol. 2021 Dec 13;19(12):e3001399. doi: 10.1371/journal.pbio.3001399. eCollection 2021 Dec.

Abstract

Ischemic stroke is a major cause of death and long-term disability. We demonstrate that middle cerebral artery occlusion (MCAO) in mice leads to a strong decline in dendritic arborization of penumbral neurons. These defects were subsequently repaired by an ipsilateral recovery process requiring the actin nucleator Cobl. Ischemic stroke and excitotoxicity, caused by calpain-mediated proteolysis, significantly reduced Cobl levels. In an apparently unique manner among excitotoxicity-affected proteins, this Cobl decline was rapidly restored by increased mRNA expression and Cobl then played a pivotal role in poststroke dendritic arbor repair in peri-infarct areas. In Cobl knockout (KO) mice, the dendritic repair window determined to span day 2 to 4 poststroke in wild-type (WT) strikingly passed without any dendritic regrowth. Instead, Cobl KO penumbral neurons of the primary motor cortex continued to show the dendritic impairments caused by stroke. Our results thereby highlight a powerful poststroke recovery process and identified causal molecular mechanisms critical during poststroke repair.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / metabolism
  • Actins / metabolism
  • Animals
  • Cytoskeletal Proteins / metabolism
  • Gene Expression / genetics
  • Infarction, Middle Cerebral Artery
  • Ischemic Stroke / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microfilament Proteins / genetics
  • Microfilament Proteins / metabolism*
  • Microfilament Proteins / physiology
  • Neuronal Plasticity / physiology*
  • Neurons / metabolism
  • Neurons / physiology

Substances

  • Actins
  • Cobl protein, mouse
  • Cytoskeletal Proteins
  • Microfilament Proteins

Grants and funding

This work was supported by grants from the DFG (Deutsche Forschungsgemeinschaft) to M.M.K. (KE685/3-2) and to B.Q. (RTG1715) as well as by the IZKF (Interdisziplinäres Zentrum für klinische Forschung des Universitätsklinikums Jena) to B.Q. and C.F. (RTG1715 SP18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.